share_log

Baird Maintains Outperform on Bio-Techne, Raises Price Target to $81

Benzinga ·  May 2 06:51

Baird analyst Catherine Schulte maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $73 to $81.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment